Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference57 articles.
1. Akao Y, Nakagawa Y, Hirata I et al (2010) Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther 17:398–408
2. Barbour AP, Reeder JA, Walsh MD, Fawcett J, Antalis TM, Gotley DC (2003) Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3. Cancer Res 63:887–892
3. Cioce M, Strano S, Muti P, Blandino G (2016) Mir 145/143: tumor suppressor, oncogenic microenvironmental factor or both? Aging-US 8:1153–1155
4. Cupp J, Culakova E, Poniewierski MS, Dale DC, Lyman GH, Crawford J (2018) Analysis of factors associated with in-hospital mortality in lung cancer chemotherapy patients with neutropenia. Clin Lung Cancer 19:e163–e169
5. Daige CL, Wiggins JF, Priddy L, Nelligan-Davis T, Zhao J, Brown D (2014) Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer. Mol Cancer Ther 13:2352–2360
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献